Consistent with this idea, we further demonstrate that deletion of Smo along with both Trp53 and Rb1 in Osx expressing cells blocks osteosarcoma formation, and instead resulted in the formation of highly differentiated benign bone tumors. This evidence concerns the gene SMO and bone neoplasm.